Pushing the boundaries of liver resection for liver cancer.

Advances in surgical planning and molecular understanding have expanded the resectability of liver cancers, with a focus on hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

• Why it matters: Liver resection remains essential for curing primary liver cancers, but challenges like cirrhosis and unresectability limit treatment options, necessitating improved strategies to increase patient eligibility.
• What they did: The study reviews surgical and integrative approaches, including assessing liver volume and function, as well as molecular insights, to downstage tumors and convert unresectable cases into candidates for surgery.
• The result: These developments enable more patients to undergo successful resection, potentially improving survival outcomes and paving the way for further innovations in liver cancer treatment.